[{"id":"e2de4bae-d52d-43ef-8d92-741aafbfdceb","acronym":"ONO-7018-01","url":"https://clinicaltrials.gov/study/NCT05515406","created_at":"2022-08-25T12:57:15.308Z","updated_at":"2025-02-25T14:02:58.817Z","phase":"Phase 1","brief_title":"A Study to Investigate the Safety, Tolerability, PK, PD, and Efficacy of ONO-7018 in Patients With R/R NHL or CLL","source_id_and_acronym":"NCT05515406 - ONO-7018-01","lead_sponsor":"Ono Pharmaceutical Co. Ltd","biomarkers":" MALT1","pipe":"","alterations":" ","tags":["MALT1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CTX-177"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 108","initiation":"Initiation: 02/13/2023","start_date":" 02/13/2023","primary_txt":" Primary completion: 12/01/2027","primary_completion_date":" 12/01/2027","study_txt":" Completion: 12/01/2027","study_completion_date":" 12/01/2027","last_update_posted":"2025-02-19"},{"id":"8258969e-d88e-4ec9-8ff8-f46b03ce6829","acronym":"SGR-1505-101","url":"https://clinicaltrials.gov/study/NCT05544019","created_at":"2022-09-16T14:56:40.430Z","updated_at":"2024-07-02T16:34:37.249Z","phase":"Phase 1","brief_title":"Study of SGR-1505 in Mature B-Cell Neoplasms","source_id_and_acronym":"NCT05544019 - SGR-1505-101","lead_sponsor":"Schrödinger, Inc.","biomarkers":" BCL2","pipe":"","alterations":" ","tags":["BCL2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e SGR-1505"],"overall_status":"Recruiting","enrollment":" Enrollment 52","initiation":"Initiation: 04/10/2023","start_date":" 04/10/2023","primary_txt":" Primary completion: 03/01/2026","primary_completion_date":" 03/01/2026","study_txt":" Completion: 03/01/2026","study_completion_date":" 03/01/2026","last_update_posted":"2024-06-07"}]